Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Where are We Going?:

Where are We Going?: Journal if INTEGJlATEI) CARE EDITORIAL Brian W. Ellis Three years ago, the Department of Health published clinical systems. However, we did see the emergence an executive letter, EL(94)94,1 giving an initial of small software houses that developed clinical sys­ tems; they did at least produce 'what the doctor response to the question of the relationship between commercial organizations and the NHS in the area of ordered', but they were mostly 'stand alone'. Thus, disease management. That document was seen by clinicians, if they were lucky enough to have the many as somewhat rigorous, and was blamed for money, had a system that required data entry for stifling further evolution of partnerships between the patient details and activity separate from the PAS. The pharmaceutical industry and the NHS. More advice in result was incompatible activity profiles between clin­ the arena of primary care was offered in the White icians and their managers. There was little incentive Paper Choice and Opportunity in 1996,2 but further for these clinical system suppliers to spend huge sums guidance was promised; it was due a year ago. The of money effecting interfaces to the many PAS sys­ matter seems to have been 'kicked into touch' http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Integrated Care SAGE

Where are We Going?:

Journal of Integrated Care , Volume 2 (2): 2 – Nov 3, 2016

Loading next page...
 
/lp/sage/where-are-we-going-RfntR6qMFZ
Publisher
SAGE
Copyright
Copyright © 2022 by SAGE Publications
ISSN
1462-4567
DOI
10.1177/146245679800200201
Publisher site
See Article on Publisher Site

Abstract

Journal if INTEGJlATEI) CARE EDITORIAL Brian W. Ellis Three years ago, the Department of Health published clinical systems. However, we did see the emergence an executive letter, EL(94)94,1 giving an initial of small software houses that developed clinical sys­ tems; they did at least produce 'what the doctor response to the question of the relationship between commercial organizations and the NHS in the area of ordered', but they were mostly 'stand alone'. Thus, disease management. That document was seen by clinicians, if they were lucky enough to have the many as somewhat rigorous, and was blamed for money, had a system that required data entry for stifling further evolution of partnerships between the patient details and activity separate from the PAS. The pharmaceutical industry and the NHS. More advice in result was incompatible activity profiles between clin­ the arena of primary care was offered in the White icians and their managers. There was little incentive Paper Choice and Opportunity in 1996,2 but further for these clinical system suppliers to spend huge sums guidance was promised; it was due a year ago. The of money effecting interfaces to the many PAS sys­ matter seems to have been 'kicked into touch'

Journal

Journal of Integrated CareSAGE

Published: Nov 3, 2016

References